Canada Markets closed

Non-Invasive Prenatal Testing (NIPT) Market Size to Surpass US$ 11 billion by 2030

·5 min read

PUNE, India, Oct. 28, 2020 (GLOBE NEWSWIRE) -- The Global Non-Invasive Prenatal Testing (NIPT) Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies, research & development activities, supply chain analysis, competitive landscape, and market composition analysis.

The Global Non-Invasive Prenatal Testing Market was valued at US$ 2.75 billion in 2019 and is expected to surpass US$ 11 billion by 2030 at a CAGR of 16% during 2020 and 2030. The average age of pregnant women has gone up across the globe. This has increased the risk of babies born with genetic abnormalities such as Down Syndrome, Turner Syndrome, Edwards Syndrome and so on. The advent of non-invasive prenatal testing happened to detect such abnormalities in the fetus in a safe manner. The daunting task of identifying possibility of genetic abnormalities is made possible through a simple blood test, hence non-invasive in nature. Along with being non-invasive this technique delivers accurate results. The test is a simple blood test and can be successfully conducted as early as first trimester of pregnancy. The changing lifestyle across masses has led to an increased count of genetic abnormalities in babies born worldwide. Lack of care during pregnancy might also lead to such irreversible abnormalities in new born kids. The evolution of technology has encouraged the users to choose non-invasive prenatal testing technique to get necessary tests in advance.

View the report with Table of Contents :

The supportive government initiatives and necessary reimbursement provisions ensure the awareness of non-invasive prenatal testing across masses. The invasive and other alternative techniques still persist in the industry and do have higher accuracy as compared to the non-invasive prenatal testing. Also, the cost associated with non-invasive tests is relatively high. However, the constant evolution of genome sequencing technologies is expected to pave the path of non-invasive prenatal testing market growth through the forecast period. The most important Majority of global players are investing in Research & Development for advancing the NIPT techniques. These efforts will pay off and the non-invasive prenatal testing demand is expected to witness healthy growth rate through the forecast period.

Access Sample of this Report :

Next-generation sequencing technique holds high potential

The technical advancement introduced in Next-Generation Sequencing (NGS) technique makes it a preferred choice by the doctors for early and accurate detection of genetic disorders. It is believed that NGS provides a platform for locating cfDNA circulating in blood. Many leading players’ such as Illumina use NGS technique in their non-invasive prenatal testing kits. They claim that the test failure rates remain extremely low with the help of whole-genome sequencing.

High prevalence of Down Syndrome makes it the most common application

Down Syndrome is one of the largest applications of the non-invasive prenatal testing. This is because Down Syndrome is the most commonly encountered chromosomal disorder amongst babies born globally. As per the statistics released by Centers for Disease Control and Prevention (CDC), about 1 in every 700 babies born suffer from this disorder. It is vital for a pregnant woman to go for a screening of the syndrome during the first trimester, which is made possible through non-invasive prenatal testing. This application segment contributes the most to the NIPT market worldwide and is anticipated to maintain the dominance throughout the forecast period.

Related report :

Global Sepsis Diagnostics Market :

Global Wound Closure Strips Market :

Global Flow Cytometry Market

Diagnostics Centers contribute heavily to the overall revenue generated

The non-invasive prenatal testing is conducted in hospitals as well as diagnostics centers. Hospitals have always been a volume generator of business however, the independent diagnostics centers have a high potential. The range and quality of services offered by diagnostics centers have been on a rise. End users prefer conducting important tests in their trusted diagnostics centers. Extended service portfolio of diagnostics centers includes home service and this has helped them in client retention. The diagnostic centers are well equipped for all high end tests unlike earlier. The segment is anticipated to witness relatively high growth throughout the forecast period.

Higher adoption of minimally invasive diagnostics procedures across North America makes it a leader in revenue generation

More than half the global demand for NIPT is experienced across North America region. The increased number of births with genetic disorders in the United States led to a rising need for the non-invasive prenatal testing. Also, the adoption of minimally invasive diagnostics procedures is high across North America. The advanced technology available with the diagnostics centers and extended payer’s coverage for pregnancy risks are favorable for the NIPT growth in North America. Population across Asia Pacific region is becoming aware about the benefits of early diagnosis and minimally invasive diagnostics procedures. This ensures a healthy growth of non-invasive prenatal testing market across the region.

Major players active in the global Cold Laser Therapy Market include BGI Genomics, Berry Genomics, Natera, Illumina, LabCorp, F. Hoffmann-La Roche Ltd., Medgenome Claria, LifeLabs Genetics, Eurofins Biomnis, Lilac Insights Pvt. Ltd., GENDIA, Dante Labs, Sequenom.

Buy This Report :

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details please contact our research and consulting team at

Contact Us:



Phone (USA) : +1 707 736 6633 Email address :